Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Education Needed To Eliminate 'Nocebo' Effect, Pfizer Says

Aug 28 2018

• By Derrick Gingery

LI-2 Protein_564977620_1200.jpg

Related Content

Enthusiasm For US Biosimilars Wanes For Some, But Not Others

Aug 15 2018

Pfizer Wants FDA To Stop Sponsor Promos From Implying Biosimilars Are Inferior

Aug 28 2018

Biosimilar Hearing Will Consider Whether 'Umbrella' Exclusivity Policy Warranted

Jul 25 2018

Biosimilars: US FDA Education Campaign Is Non-Committal On Non-Medical Switching

Oct 25 2017

Pending Biosimilars

Feb 13 2017

FDA Biosimilar Education Campaign Will Need To Be Targeted

Sep 17 2015

Related Companies

Pfizer Inc.

Additional Topics

United States Biosimilars FDA Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window